CoChat

THERAPY OF ENDOCRINE DISEASE: Perspectives on the management of adrenal insufficiency: clinical insights from across Europe

Open access
Grossman, Ashley, Johannsson, Gudmundur, Quinkler, Marcus, Zelissen, Pierre · 2013 · European Journal of Endocrinology

The DOI matches its Crossref record; 67 of the 67 references it cites were found in a registry or an index.

Abstract

Background: Conventional glucocorticoid (GC) replacement for patients with adrenal insufficiency (AI) is inadequate. Patients with AI continue to have increased mortality and morbidity and compromised quality of life despite treatment and monitoring. Objectives: i) To review current management of AI and the unmet medical need based on literature and treatment experience and ii) to offer practical advice for managing AI in specific clinical situations. Methods: The review considers the most urgent questions endocrinologists face in managing AI and presents generalised patient cases with suggested strategies for treatment. Results: Optimisation and individualisation of GC replacement remain a challenge because available therapies do not mimic physiological cortisol patterns. While increased mortality and morbidity appear related to inadequate GC replacement, there are no objective measures to guide dose selection and optimisation. Physicians must rely on experience to recognise the clinical signs, which are not unique to AI, of inadequate treatment. The increased demand for corticosteroids during periods of stress can result in a life-threatening adrenal crisis (AC) in a patient with AI. Education is paramount for patients and their caregivers to anticipate, recognise and provide proper early treatment to prevent or reduce the occurrence of ACs. Conclusions: This review highlights and offers suggestions to address the challenges endocrinologists encounter in treating patients with AI. New preparations are being developed to better mimic normal physiological cortisol levels with convenient, once-daily dosing which may improve treatment outcomes.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1530/eje-13-0450

Cites

67 of 67 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Results of an electronic survey regarding (a) short-term and (b) long-term goals in the treatment of patients with adrenal insufficiency among the participants of the German Endocrine Society Meeting in March 2013 (black bars) and of the British Endocrine Society in March 2013 (white bars). Participants (28 from Germany and 36 from UK) included endocrinologists (54.6 and 69.4%), other clinicians (10.7 and 5.6%), researchers (10.7 and 11.1%), nurses (7.1 and 8.3%) and others (17.9 and 5.6%), respectively.
Figure 1 Results of an electronic survey regarding (a) short-term and (b) long-term goals in the treatment of patients with adrenal insufficiency among the participants of the German Endocrine Society Meeting in March 2013 (black bars) and of the British Endocrine Society in March 2013 (white bars). Participants (28 from Germany and 36 from UK) included endocrinologists (54.6 and 69.4%), other clinicians (10.7 and 5.6%), researchers (10.7 and 11.1%), nurses (7.1 and 8.3%) and others (17.9 and 5.6%), respectively.CC BY · PubMed Central
Figure 2 Results of an electronic survey among the participants of the German Endocrine Society Meeting in March 2013 (black bars) and of the British Endocrine Society in March 2013 (white bars) regarding (a) the three main challenges with the present treatment regimens of conventional therapy and (b) the current assessment of well-being and quality of life in patients with adrenal insufficiency.
Figure 2 Results of an electronic survey among the participants of the German Endocrine Society Meeting in March 2013 (black bars) and of the British Endocrine Society in March 2013 (white bars) regarding (a) the three main challenges with the present treatment regimens of conventional therapy and (b) the current assessment of well-being and quality of life in patients with adrenal insufficiency.CC BY · PubMed Central
Figure 3 The Original Swedish Emergency Card was created by Dahlqvist et al. (56) in the Swedish Addison Registry and the Swedish Endocrine Society. This card was chosen for use among all other emergency cards used in Europe by an independent expert panel of European endocrinologists. Full colour version of this figure available via http://dx.doi.org/10.1530/EJE-13-0450.
Figure 3 The Original Swedish Emergency Card was created by Dahlqvist et al. (56) in the Swedish Addison Registry and the Swedish Endocrine Society. This card was chosen for use among all other emergency cards used in Europe by an independent expert panel of European endocrinologists. Full colour version of this figure available via http://dx.doi.org/10.1530/EJE-13-0450.CC BY · PubMed Central
Figure 4 Interfering concomitant medications – mechanism of action. (A) Drugs inducing production of cortical-binding globulin might lower free unbound HC. (B) Drugs interfering with hepatic CYP3A4 influence HC metabolism causing GC under- or over-replacement. (C) Drugs might influence intestinal absorption of hydrocortisone. (D) Drugs modulating hepatic 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) influence HC half-life. Full colour version of this figure available via http://dx.doi.org/10.1530/EJE-13-0450.
Figure 4 Interfering concomitant medications – mechanism of action. (A) Drugs inducing production of cortical-binding globulin might lower free unbound HC. (B) Drugs interfering with hepatic CYP3A4 influence HC metabolism causing GC under- or over-replacement. (C) Drugs might influence intestinal absorption of hydrocortisone. (D) Drugs modulating hepatic 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) influence HC half-life. Full colour version of this figure available via http://dx.doi.org/10.1530/EJE-13-0450.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 1

  1. Zelissen PMJ. Addison Patients in The Netherlands. Medical Report of the Survey. Dutch Addison Society, 1994.

Cited by

See all 127

Metadata

Authors
Grossman, A., Johannsson, G., Quinkler, M., & Zelissen, P.
Affiliations
  • Churchill Hospital (GB)
  • Utrecht University (NL)
Corresponding author
Grossman, Ashley
Venue
European Journal of Endocrinology
Published
2013-12
Volume
169
Issue
6
Pages
R165-R175
ISSN
  • 0804-4643 (ISSN-L)
  • 1479-683X
OpenAlex
W2126102668
Cited by
119
References
67
Citations by year
2026: 3 · 2025: 4 · 2023: 6 · 2022: 7 · 2021: 9 · 2020: 8 · 2019: 13 · 2018: 8 · 2017: 18 · 2016: 12 · 2015: 18 · 2014: 13
FWCI
2.10
Type
journal article
Language
en
Open access
Locations
  • European Journal of Endocrinology (publishedVersion, cc-by-nc)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
Viropharma
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
  • Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal Regulation and Hypertension
Keywords
adrenal insufficiency, glucocorticoid replacement therapy, adrenal crisis, stress-dose corticosteroids, cortisol replacement therapy, patient education, unmet medical needs
MeSH terms
Addison Disease, Adrenal Insufficiency, Cardiovascular Diseases, Circadian Rhythm, Dehydroepiandrosterone, Drug Administration Schedule, Emergency Treatment, Europe, Female, Glucocorticoids, Humans, Hydrocortisone, Hypothyroidism, Injections, Intravenous, Male, Mineralocorticoids, Pregnancy, Pregnancy Complications, Quality of Life, Risk Factors, Drug Design, Drugs, Investigational, Treatment Outcome, Diabetes Complications

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.